Anxiolytic activity of Vitex negundo Linn. in experimental models of anxiety in mice

R. S. Adnaik, P. T. Pai, V. D. Sapakal, N. S. Naikwade, C. S. Magdum


The purpose of this study was to characterize the putative anxiolytic-like activity of an ethanolic extract prepared from the roots of Vitex negundo (VN) using the elevated plus maze (EPM) and light–dark exploration test in mice. Male mice were either treated orally with the VN extract or the positive control diazepam, respectively, 1 hour before behavioral evaluation. Oral administration of 100 and 200 mg/kg of VN extract significantly (P > 0.01) increased the percentage time spent on and the number of entries into the open
arms of the EPM. The effect was comparable to that of the benzodiazepine diazepam (2 mg/kg p.o.). In light–dark exploration test, diazepam-treated rats significantly increased the time spent in light arena and decreased the duration of immobility, while VN treated rats also showed a significant (P >0.01) increase in the time spent (100 and 200 mg/kg) in light arena. Diazepam and the VN extracts do not produced any overt motor dysfunction. These results indicate that VN is an effective anxiolytic agent. In conclusion, the action of extract upon the anxiety models tested are in accord with the traditional use of VN L. and could be useful in primary medical care.
Key words: Vitex negundo, anxiolytic, elevated plus maze, light–dark exploration, locomotor activity

Full Text:



Barar FSK. Essentials of Pharmacotheraupetics. New Delhi: S.

Chand and Company Ltd; 2005. p. 89.

Eisenberg RB, Davis SL, Ettner S, Appel S, Wilkey M, Rompay V,

et al. Trends in alternative medicine used in United States: Results

of a follow up national survey. J Am Med Assoc 1998;280:1569-75.

Vogel HG, Vogel WH. Drug discovery and evaluation. Heidelberg,

Springer, New York: 2002. p. 401.

Satoskar RS, Bhandarkar SD, Rege NN. Pharmacology and

Pharmacotheraupetics. 19th ed. Mumbai: Popular Prakashan;

p. 198.

Griffiths RR, Sannerud CA. Abuse of and dependence

on Benzodiazepines and Other axiolytic/sedative Drugs.

Psychopharmacology Services. 3rd ed. New York: Raven Press;

p. 1535-40.

Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of

triazolam: experimental measurements in animals and humans.

Psychopharmacological Services. 3rd ed. New York: Raven Press;

. 83-7.

Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible

anxiolytic effects of chrysin: A central benzodiazepine receptor

ligand isolated from Passiflora coerulea. Pharmacol Biochem

Behav 1994;47:1-4.

Viola H, Stein ML de, Wolfman C. Apigenin. A component of

Matricaria recutita flowers, is a central benzodiazepine receptorligand

with anxiolytic effects. Planta Med 1996;61:213-6.

Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina

JH. Anxiolytic natural and synthetic flavonoid ligands of the

central benzodiazepine receptor have no effect on memory tasks

in rats. Pharmacol Biochem Behav 1997;58:887-91.

Paladini C, Marder M, Viola H, Wolfman C, Wasowski C, Medina

JH. Flavonoids and the central nervous system: From forgotten

factors to potent anxiolytic compounds. J Pharmacy Pharmacol


Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine

dependence in mice by a tri-substituted benzoflavone moiety of

Passiflora incarnata Linneaus: A non-habit forming anxiolytic. J

Pharma Pharma Sci 2003;6:215-22.

Heinrich M, Gibbons S. Ethanopharmacology in drug discovery:

An analysis of its role and potential contribution. J Pharmacy

Pharmacol 53:425-32.

Beaubrum G, Gray GE. A review of herbal medicines for

psychiatric disorders. Psychiatr Serv 2000;51:1130-4.

Rex A, Morgenster E, Fink H. Anxiolytic-like effects of kava-kava

in the elevated plus maze test-comparison with diazepam. Progr

Neuro-Psychopharmacol Biol Psychaitry 2002;26:855-60.

Friede M, Freudenstein J. Antidepressant and Anxiolytic Effect of

St. John’s Wort Extract ZE-117. Eur Psychaitry 2002;17:96.

Une HD, Sarveiya VP, Pal SC, Kasture VS, Kasture SB. Nootropic

and Anxiolytic Activity of Saponins from Albizzia Lebbeck leaves.

Pharmacol Biochem Behav 2001;69:439-44.

Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, et al.

Steaming of ginseng at high temperature enhances biological

activity. J Nat Prod 2000;63:1702-4.

Anonymous. Directory of Indian Medicinal Plants. Lucknow:

CIMAP; 1992. p. 49.

Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Delhi:

Periodicals Experts Book Agency; 1991.

Wealth of India. New Delhi: Publication and Information, Council

of Scientific and Industrial; 1976. p. 522.

Chawla S, Sharma AK, Handa SS, Dhar KL. Chemical investigation

and anti-inflammatory activity of Vitex negundo seeds: Part I. Indian

J Chem 1991;30:773-6.

Chawla S, Sharma AK, Handa SS. Chemical investigation and

anti-inflammatory activity of Vitex negundo seeds: Part II. J Nat

Products 1992;55:163-7.

Srivastava SC, Sisodia CS. Analgesic studies on Vitex negundo and

Valeriana wallichii. Indian Veterinary J 1970;47:170-5.

Telang RS, Chatterjee S, Varshneya C. Studies on analgesic and antiinflammatory

activities of Vitex Negundo Linn. Indian J Pharmacol


Gupta M, Majumdar UK, Bhawal SR, Swami SMK. CNS activity

of petroleum ether extract of Vitex negundo Linn in mice. Indian J

Pharm Sci 1997;59:240-5.

Tamhankar P, Saraf MN. Antiarthritic activity of Vitex negundo

Linn. Indian J Pharm Sci 1994;56:158-61.

Nair M, Rajagopalan V, Saraf MN. Antiallergic activity of Vitex

negundo Linn. Chandigarh: Paper presented at the 46th Indian

Pharmaceutical Congress; 1994.

Nair M. Studies on the antiallergic activity of Vitex negundo Linn.

A thesis submitted to the University of Bombay for the M.Pharm

degree 1994.

Nair M, Tamhankar CP, Saraf MN. Studies on the mast cell stabilising

activity of Vitex negundo Linn. Indian Drugs 1995;32:277-82.

Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS,

Ratnasooriya WD. Anti-inflammatory and analgesic activities

of mature fresh leaves of Vitex negundo. J Ethnopharmacol


Tandon VR, Gupta RK. An experimental evaluation of

anticonvulsant activity of Vitex negundo. Indian J Physiol Phamocol


Tandon V, Gupta RK. Vitex negundo Linn (VN) leaf extract as an

adjuvant therapy to standard anti-inflammatory drugs. Indian J

Med Res 2006;124:447-50.

Kulkarni SK, Reddy DS. Animal behavioral models for testing antianxiety

activity. Met Finds Exp Clin Pharmacol 1996;18:219–40.

Vogel HG, Vogel WHO. Drug Discovery and Evaluation. Germany:

Heidelberg, Springer; 1997. p. 378–9.

Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ.

Zacopride: Anxiolytic profile in rodent and primate models of

anxiety. J Pharmacy Pharmacol 1988;40:302-5.

Crawley JN, Goodwin FK. Neuropharmacologic specificity of a

simple animal model for the behavioral actions of benzodiazepines.

Pharmacol Biochem Behav 1981;15:595-9.

Amborgi LC, Giachetti A. Some factors influencing conditioned

and spontaneous behaviour of rats in the light-dark box test.

Physiol Behav 1986;36:97-101.

Kulkarni SK. Handbook of experimental pharmacology. 3rd ed.

New Delhi: Vallabh Prakashan 2005. p. 117-9.

Dawson GR, Tricklebank MD. Use of the elevated plus maze

in search for novel anxiolytic agents. Trends Pharmacol Sci


Soderpalm R, Hjorth S, Engel JA. Effects of 5-HTA Receptor

agonists and L-5-HTP in montgomery’s conflict test. Pharmacol

Biochem Behav 1989;32:259-65.

Treit D. Animal models for the study of anti-anxiety agents: A

review. Neurosci Biobehav Rev 1985;9:203-22.

Lewis JJ. An introduction to pharmacology. London: E. S.

Livingstone; 1980. p. 287.

Ha JH, Lee DU, Lee JT. 4-hydroxy benzaldehyde from Gasrtrodia

elata as active in the antioxidation and GABA ergic neuromodulation

of the rat brain. J Ethnopharmacol 2000;73:329-33.



  • There are currently no refbacks.